Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Development and successful clinical application of preimplantation genetic haplotyping for Herlitz junctional epidermolysis bullosa.
[junctional epidermolysis bullosa]
Herlitz
junctional
epidermolysis
bullosa
(
HJEB
)
is
a
severe
,
life-threatening
,
autosomal
recessive
blistering
skin
disease
for
which
no
cure
is
currently
available
.
Prenatal
diagnosis
for
couples
at
risk
is
feasible
through
fetal
skin
biopsy
or
analysis
of
DNA
extracted
from
chorionic
villi
,
but
these
methods
can
be
applied
only
after
pregnancy
has
been
established
.
An
alternative
approach
,
which
involves
the
analysis
of
single
cells
from
embryos
prior
to
establishment
of
pregnancy
,
is
preimplantation
genetic
diagnosis
(
PGD
)
.
Until
now
,
its
clinical
uptake
has
been
hindered
by
lengthy
delays
in
establishing
mutation
-
specific
protocols
,
and
by
the
small
amount
of
template
DNA
that
can
be
obtained
from
a
single
cell
.
A
new
method
that
addresses
these
problems
,
preimplantation
genetic
haplotyping
(
PGH
)
,
relies
on
whole
genome
amplification
followed
by
haplotyping
of
multiple
polymorphic
markers
using
standard
DNA-based
polymerase
chain
reaction
(
PCR
)
assays
.
To
design
and
validate
a
generic
PGH
assay
for
HJEB
and
to
transfer
this
into
clinical
practice
.
We
established
a
multiplex
PCR-based
PGH
assay
involving
16
markers
within
and
flanking
the
LAMB
3
gene
(
the
most
frequently
mutated
gene
in
HJEB
)
.
The
assay
was
then
validated
in
10
families
with
at
least
one
previously
affected
offspring
.
After
licensing
by
the
Human
Fertilisation
and
Embryology
Authority
(
HFEA
)
,
the
new
test
was
used
for
PGD
in
a
couple
at
risk
of
HJEB
.
T
he
chromosome
1
LAMB
3
markers
within
the
assay
were
shown
to
be
of
sufficient
heterogeneity
to
have
widespread
application
for
preimplantation
testing
of
HJEB
.
In
one
couple
that
were
heterozygous
carriers
of
nonsense
mutations
in
LAMB
3
,
we
used
the
new
assay
to
identify
unaffected
embryos
in
a
series
of
PGD
cycles
.
Pregnancy
was
established
in
the
third
PGD
cycle
and
a
healthy
,
unaffected
child
was
born
.
DNA
analysis
of
cord
blood
confirmed
the
predicted
single
-cell
mutation
status
of
wild-
type
LAMB
3
alleles
.
PGH
represents
a
major
step
forward
in
widening
the
scope
and
availability
of
preimplantation
testing
for
serious
mapped
single
-
gene
disorders
.
We
have
established
a
generic
test
that
is
suitable
for
the
majority
of
couples
at
risk
of
HJEB
.
Diseases
Validation
Diseases presenting
"prenatal diagnosis"
symptom
22q11.2 deletion syndrome
achondroplasia
adrenomyeloneuropathy
alexander disease
alpha-thalassemia
aromatase deficiency
benign recurrent intrahepatic cholestasis
cadasil
canavan disease
classical phenylketonuria
cohen syndrome
congenital adrenal hyperplasia
congenital diaphragmatic hernia
congenital toxoplasmosis
cystinuria
dentinogenesis imperfecta
epidermolysis bullosa simplex
harlequin ichthyosis
holt-oram syndrome
homocystinuria without methylmalonic aciduria
hydrocephalus with stenosis of the aqueduct of sylvius
junctional epidermolysis bullosa
kindler syndrome
krabbe disease
lamellar ichthyosis
megacystis-microcolon-intestinal hypoperistalsis syndrome
monosomy 21
neonatal adrenoleukodystrophy
oculocutaneous albinism
omenn syndrome
phenylketonuria
primary hyperoxaluria type 1
pyruvate dehydrogenase deficiency
severe combined immunodeficiency
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom